Filing Details
- Accession Number:
- 0001641489-24-000078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 16:31:06
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-19 16:31:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641489 | Vtv Therapeutics Inc. | VTVT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1264519 | J Paul Sekhri | C/O Vtv Therapeutics Inc. 3980 Premier Drive, Suite 310 High Point NC 27265 | Pres, Ceo And Exec Chairperson | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-11-15 | 1,378 | $16.35 | 1,378 | No | 4 | P | Direct | |
| Class A Common Stock | Acquisiton | 2024-11-15 | 1,778 | $16.88 | 3,156 | No | 4 | P | Direct | |
| Class A Common Stock | Acquisiton | 2024-11-18 | 1,844 | $16.96 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Sekhri on August 13, 2024.
- The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $16.50. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.71 to $17.00. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.70 to $17.00. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
